| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |